Search

everythinglearnresearchcommunity

for

Search:↓

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

Childhood atopic dermatitis does not significantly affect general cognition.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

Vitamin D is important for skin health and can help treat psoriasis, atopic dermatitis, and vitiligo.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Inflammatory skin conditions are the most common in Brazilian children, with atopic dermatitis being the top issue.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Type 2 cytokines IL-4 and IL-13 increase skin's vulnerability to Staphylococcus aureus, which could be important for treating atopic dermatitis.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

The document concludes that atopic dermatitis in dogs is managed with various treatments including antipruritics, supplements, and possibly immunotherapy.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Bleach baths with 0.005% hypochlorite help manage atopic dermatitis by affecting skin cells and reducing itchiness.

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.